Back to User profile » Dr Huafang Li

Papers published by Dr Huafang Li:

Original Research

A Random Forest Model for Predicting Social Functional Improvement in Chinese Patients with Schizophrenia After 3 Months of Atypical Antipsychotic Monopharmacy: A Cohort Study

Li Y, Zhang L, Zhang Y, Wen H, Huang J, Shen Y, Li H

Neuropsychiatric Disease and Treatment 2021, 17:847-857

Published Date: 19 March 2021

Clinical Trial Report

Efficacy of low-dose D2/D3 partial agonist pramipexole on neuroleptic-induced extrapyramidal symptoms and symptoms of schizophrenia: a stage-1 open-label pilot study

Weng JJ, Wang LH, Zhu H, Xu WR, Wei YM, Wang ZY, Yu WJ, Li HF

Neuropsychiatric Disease and Treatment 2019, 15:2195-2203

Published Date: 7 August 2019

Original Research

Impact of time of initiation of once-monthly paliperidone palmitate in hospitalized Asian patients with acute exacerbation of schizophrenia: a post hoc analysis from the PREVAIL study

Li H, Li Y, Feng Y, Zhuo J, Turkoz I, Mathews M, Tan W

Neuropsychiatric Disease and Treatment 2018, 14:1107-1117

Published Date: 26 April 2018

Original Research

Safety and efficacy of paliperidone extended-release in Chinese patients with schizophrenia: a 24-week, open-label extension of a randomized, double-blind, placebo-controlled study

Zhang H, Li H, Liu Y, Wu C, Wu Q, Nuamah I, Shi J, Xie S, Wang G, Gopal S

Neuropsychiatric Disease and Treatment 2016, 12:69-77

Published Date: 8 January 2016

Original Research

Efficacy and safety of once-monthly injection of paliperidone palmitate in hospitalized Asian patients with acute exacerbated schizophrenia: an open-label, prospective, noncomparative study

Li HF, Turkoz I, Zhang F

Neuropsychiatric Disease and Treatment 2016, 12:15-24

Published Date: 21 December 2015